CPIG
HUMA icon

Chicago Partners Investment Group’s Humacyte HUMA Stock Holding History

Chicago Partners Investment Group’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.3K Sell
33,346
-4,099
-11% -$3.8K ﹤0.01% 1540
2026
Q1 		$26.4K Buy
+37,445
New +$38.9K ﹤0.01% 1446

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Chicago Partners Investment Group's HUMA Position: Q2 2026 in Review

Chicago Partners Investment Group reduced its Humacyte (HUMA) stake by 11% in Q2 2026, selling an estimated $3.8K and leaving 33,346 shares worth $21.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1540.

Chicago Partners Investment Group first reported a position in HUMA in Q1 2026 and has held it in 2 quarters since. The position peaked at $26.4K in Q1 2026. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Chicago Partners Investment Group held 33,346 shares of Humacyte worth $21.3K as of Q2 2026.
  • Chicago Partners Investment Group sold 4,099 Humacyte shares in Q2 2026, an estimated $3.8K.
  • Humacyte made up ﹤0.01% of Chicago Partners Investment Group's portfolio in Q2 2026, its #1540 holding.
  • Chicago Partners Investment Group first reported a position in Humacyte in Q1 2026 and has held it in 2 quarters since.
  • Chicago Partners Investment Group's Humacyte position peaked at $26.4K in Q1 2026.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.